TARDBP and amyotrophic lateral sclerosis: Kasai et al., by measuring TDP-43 using Simoa analyzer in a cohort of 29 ALS patients and 29 age-matched controls, found increased levels of the biomarker in both the CSF and plasma of ALS patients [27].